Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566)

Overview

Jiangsu Jibeier Pharmaceutical Co., Ltd., founded in 2001 and based in Zhenjiang, China, stands as a vital player in the pharmaceutical industry. The company is deeply engaged in the research, development, production, and sale of a broad range of pharmaceutical products. It specializes in chemical pharmaceutical preparations, traditional Chinese medicine, and various drug therapies. With a strong emphasis on innovation and quality healthcare solutions, Jiangsu Jibeier Pharmaceutical Co., Ltd. aims at addressing a multitude of health concerns, effectively contributing to the well-being of communities on a global scale.

Products and Services

The comprehensive portfolio of Jiangsu Jibeier Pharmaceutical Co., Ltd. spans across an array of therapeutic areas, each targeted towards improving patient health and quality of life. Below is a detailed rundown of its key products and services:

• Improving White Blood Cells: The company has developed drugs aimed at aiding the production of white blood cells, crucial for the body's immune response.
• Anti-Hypertension: It offers innovative solutions for managing and treating hypertension, helping to reduce the risk of heart disease and stroke.
• Enhancing Immunity: Immunity-boosting drugs are part of its portfolio, designed to strengthen the body's defense against infections and diseases.
• Treating Joint Diseases: The company provides treatments for various joint diseases, aiming to improve mobility and reduce pain for sufferers.
• Anti-Eye Infection: Eye drops and other medications specifically formulated to fight eye infections are offered, ensuring eye health and preventing vision impairment.
• Treating Bronchitis: Medications for the treatment of bronchitis are available, focusing on alleviating symptoms and promoting lung health.
• Protecting Liver Function: With a range of liver protection drugs, the company aims at supporting liver health and preventing liver-related diseases.

In addition to these established therapeutic areas, Jiangsu Jibeier Pharmaceutical Co., Ltd. is actively engaged in the development of drugs for treating depression, tumors, stomach and gastric diseases among other conditions. Its commitment to expanding its pharmaceutical range underscores the company's dedication to addressing the complex and evolving healthcare needs of its clientele. Moreover, its versatile product lineup is made available in various dosage forms, including tablets, capsules, and eye drops, ensuring accessibility and convenience for patients across different demographics.